ETON Annual Accounts Payable
$1.85 M
+$82.00 K+4.64%
31 December 2023
Summary:
As of January 20, 2025, ETON annual accounts payable is $1.85 million, with the most recent change of +$82.00 thousand (+4.64%) on December 31, 2023. During the last 3 years, it has fallen by -$496.00 thousand (-21.16%). ETON annual accounts payable is now -21.16% below its all-time high of $2.34 million, reached on December 31, 2020.ETON Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ETON Quarterly Accounts Payable
$2.68 M
+$551.00 K+25.83%
30 September 2024
Summary:
As of January 20, 2025, ETON quarterly accounts payable is $2.68 million, with the most recent change of +$551.00 thousand (+25.83%) on September 30, 2024. Over the past year, it has increased by +$836.00 thousand (+45.24%). ETON quarterly accounts payable is now -18.00% below its all-time high of $3.27 million, reached on September 30, 2021.ETON Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ETON Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.6% | +45.2% |
| 3 y3 years | -21.2% | +16.7% |
| 5 y5 years | +30.1% | +16.7% |
ETON Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4.6% | at high | +154.7% |
| 5 y | 5-year | -21.2% | +221.4% | -18.0% | +366.8% |
| alltime | all time | -21.2% | +242.9% | -18.0% | +388.9% |
Eton Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.68 M(+25.8%) |
| June 2024 | - | $2.13 M(-5.7%) |
| Mar 2024 | - | $2.26 M(+22.5%) |
| Dec 2023 | $1.85 M(+4.6%) | $1.85 M(+7.9%) |
| Sept 2023 | - | $1.71 M(-25.6%) |
| June 2023 | - | $2.30 M(+86.5%) |
| Mar 2023 | - | $1.23 M(-30.2%) |
| Dec 2022 | $1.77 M(-0.5%) | $1.77 M(+67.6%) |
| Sept 2022 | - | $1.05 M(-18.9%) |
| June 2022 | - | $1.30 M(-39.0%) |
| Mar 2022 | - | $2.13 M(+20.1%) |
| Dec 2021 | $1.77 M | $1.77 M(-45.8%) |
| Sept 2021 | - | $3.27 M(+115.0%) |
| June 2021 | - | $1.52 M(-13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $1.76 M(-24.9%) |
| Dec 2020 | $2.34 M(+307.7%) | $2.34 M(+6.2%) |
| Sept 2020 | - | $2.21 M(+13.1%) |
| June 2020 | - | $1.95 M(+65.1%) |
| Mar 2020 | - | $1.18 M(+105.7%) |
| Dec 2019 | $575.00 K(-59.5%) | $575.00 K(+4.7%) |
| Sept 2019 | - | $549.00 K(-37.8%) |
| June 2019 | - | $883.00 K(-72.5%) |
| Mar 2019 | - | $3.21 M(+125.8%) |
| Dec 2018 | $1.42 M(+163.6%) | $1.42 M(+79.2%) |
| Sept 2018 | - | $793.00 K(-8.6%) |
| June 2018 | - | $868.00 K(+8.4%) |
| Mar 2018 | - | $801.00 K |
| Dec 2017 | $539.00 K | - |
FAQ
- What is Eton Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Eton Pharmaceuticals?
- What is Eton Pharmaceuticals annual accounts payable year-on-year change?
- What is Eton Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Eton Pharmaceuticals?
- What is Eton Pharmaceuticals quarterly accounts payable year-on-year change?
What is Eton Pharmaceuticals annual accounts payable?
The current annual accounts payable of ETON is $1.85 M
What is the all time high annual accounts payable for Eton Pharmaceuticals?
Eton Pharmaceuticals all-time high annual accounts payable is $2.34 M
What is Eton Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ETON annual accounts payable has changed by +$82.00 K (+4.64%)
What is Eton Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ETON is $2.68 M
What is the all time high quarterly accounts payable for Eton Pharmaceuticals?
Eton Pharmaceuticals all-time high quarterly accounts payable is $3.27 M
What is Eton Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ETON quarterly accounts payable has changed by +$836.00 K (+45.24%)